The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| E-Paper
Search
+

    After a dismal April and May, biz back to near pre-Covid level: Dr Lal Path Labs

    Copy URL
    Embed

    Covid-19 will remain a part of portfolio but the trendline is not very clear. Sixty per cent of Covid testing coming from the government. We have not seen much business on anti-body testing, says Om Manchanda, MD.

    413views
    Have something to say? Post your comment
    The Economic Times